NEW YORK (GenomeWeb) – Illumina today priced its $1 billion convertible senior notes offering, which it expects will bring in net proceeds of approximately $985 million.

The $1 billion in senior notes is above the $900 million that the firm proposed on Wednesday when it initially announced the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.